Added to YB: 2025-06-06
Pitch date: 2025-06-05
MXCT [bullish]
MaxCyte, Inc.
-8.16%
current return
Author Info
Doheenz’s Substack shares mostly small caps and asymmetric opportunities. Sign up for the newsletter.
Company Info
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
Market Cap
$168.5M
Pitch Price
$1.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.87
P/E
-3.67
EV/Sales
2.35
Sector
Life Sciences Tools and Services
Category
growth
MaxCyte, Inc. - $MXCT
MXCT long: Electroporation platform provider down 50% YTD to $240M MC/$85M EV with $175M cash. Core business at $35M run-rate (84% GM). 29 SPL agreements generating milestone payments ($210M potential) + ~1% royalties on partner sales. CASGEVY commercialization could yield $30M+ annual royalties at peak sales of $3B+.
Read full article (4 min)